Anadi Algo News

dr devi shetty people page on Anadi Algo News

People Landing|80 matching stories

dr devi shetty News, Mentions & Market Context

AI-analyzed market coverage and mentions for dr devi shetty, including related stories and trading context.

What Traders Do Next

A market theme is more useful with a process around it.

Use these pages to understand the story first. The clarity usually comes later, after the idea is filtered, tested, and put in context.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

Here whenever you want to go deeper, never a nudge.Explore Anadi
Top Story|Economic Timesabout 10 hours ago

Chennai’s rain gets a market price: NCDEX launches RAINCHNNAI weather derivatives futures contract

Weather derivatives are crucial for managing agricultural risks in India. NCDEX is expanding its offerings to cover more regions and seasons.

Bullish
Bullish+5585%
AgricultureFinancials
+55

Impact Score

Affected Stocks

NCDEXNational Commodity & Derivatives Exchange Ltd
Positive
Positive for NCDEX and agri-related stocks; look for increased adoption of weather hedging tools.
Economic Times2 days ago

Gujarat aims to catch US shrimp orders with turtle-safe nets

This news, while positive for the seafood sector, is not directly related to the auto sector. The auto sector is currently focused on volume growth and managing commodity costs.

Neutral+2070%
5 facts
No direct trade setup for auto stocks based on this news. For auto, maintain a bias towards companies showing strong sales growth and managing input costs effectively.
Mint4 days ago

Deepinder Goyal's Temple acquires London-based longevity clinic Longevous ahead of wearable launch

Deepinder Goyal's Temple acquires London-based Longevous; founders Robert Mohr and Avi Roy join as CMO and Head of Science ahead of its wearable device's launch.

Neutral
Mint5 days ago

Global PE firm Siguler Guff eyes $350-400 mn continuation fund to back four portfolio cos

Siguler Guff is considering the fund to stay invested in value-retail chain Baazar Kolkata, multi-specialty chain Sterling Hospitals, appliance maker Luker Electric Technologies and medical device maker Relisys

Neutral

Latest dr devi shetty Mentions

Economic Times5 days ago+34.2

Lord’s Mark Industries Limited and ARKALL Holding Limited partner for healthcare expansion across Caribbean countries

5 factsHealthcare
This news is positive for Lord's Mark Industries Limited's future prospects; if it lists, consider a bullish bias based on international growth potential.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (oversold).
Economic Times6 days ago+38.1

Kedaara pumps $200m into ortho support wear maker Tynor

Neutral5 factsPOLYMEDHOSPITEXPharma
Maintain a positive bias on Indian medical device manufacturers; look for companies with strong product pipelines and distribution.|Quick check: POLYMED neutral (+0.8% 1d), HOSPITEX neutral.
Economic Times7 days ago+37.9

Kedaara Capital bets on India’s orthopaedic market with $200 million Tynor deal

5 factsHealthcareMedical Devices
Maintain a bullish bias on Indian medical device manufacturers and healthcare equipment providers, focusing on companies with strong product pipelines and distribution networks.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.8% 1d).
Economic Times7 days ago+44.9

Exports key for mobile brands to maximize Mobile Phone Manufacturing Scheme incentives: Kotak

Bearish5 factsBHARTIARTLElectronics Manufacturing ServicesTelecommunications
upside follow-through stays in play in Indian EMS and mobile manufacturing stocks that demonstrate strong export growth or have clear strategies to expand their international footprint, with a focus on companies mentioned in positive light by brokerages.|Quick check: BHARTIARTL neutral (+0.0% 1d), MARUTI bearish bias (oversold).
Mint7 days ago+19.1

Kedaara Capital invests $200 million in Tynor Orthotics

5 factsHealthcarePharmaceuticals
Maintain a bullish bias on select Indian healthcare and pharma stocks, focusing on companies with strong product pipelines or market leadership in specific medical device segments, with strict risk management.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.8% 1d).
Economic Times7 days ago+11.7

Govt eases loan licence requirement for 'outsourced' sterilisation of medical gear

5 factsHealthcare
Mixed for medical device manufacturers; positive for domestic operations, potentially negative for export-oriented firms.|Quick check: HDFCBANK bearish bias (+0.6% 1d), ICICIBANK bearish bias (+0.8% 1d).
Economic Times7 days ago+40.3

JioStar probe leads to arrest of individual in ZeeFlix piracy case; over 1,000 TV channels allegedly distributed illegally

Bearish5 factsZEELMedia & EntertainmentTelecommunications
Consider a bullish bias for Indian media and entertainment stocks, particularly those with significant OTT presence, on improved content monetization prospects.|Quick check: ZEEL neutral (-0.7% 1d), MARUTI bearish bias (oversold).
Mint8 days ago+30.5

After the lottery win: why Dr Reddy’s may be doing much more in its laboratories

Neutral5 factsDRLPharma
Neutral to slightly cautious on DRL until clear signs of pipeline success emerge. Watch for R&D updates.|Quick check: DRL bullish bias (overbought), SUNPHARMA bearish bias (oversold).
Mint8 days ago+60.3

Multibagger defence stock Apollo Micro System acquires 34% stake in defence tech company

Neutral5 factsAPOLLODefenceAerospace & Defence
Maintain a bullish bias on defence stocks, particularly those with strong R&D and strategic government alignment, with a focus on long-term growth potential.|Quick check: APOLLO neutral (-1.0% 1d), NIFTY bullish bias (+7.9% 1d).
Economic Times8 days ago+57.9

Health Ministry announces medical device regulatory reforms for ease of doing business

Neutral5 factsSIEMENSPHARMAHealthcarePharmaceuticals
Maintain a bullish bias on Indian medical device manufacturers, focusing on companies with strong R&D and manufacturing capabilities. Consider long positions with a medium-term horizon.|Quick check: SIEMENS neutral (+0.3% 1d), PHARMA neutral.
Economic Times8 days ago-6.8

Xiaomi launches new Xring chip, partners with TSMC for production, sources say

5 factsTechnologyElectronics Manufacturing
Maintain a neutral stance on Indian electronics manufacturing stocks; watch for long-term strategic shifts rather than immediate trading opportunities.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (oversold).
Economic Times10 days ago+55.8

Apple may expand manufacturing in India beyond iPhones

Neutral5 factsPGHLHONAUTElectronics Manufacturing ServicesTechnology Hardware & Equipment
Maintain a bullish bias on Indian EMS stocks, focusing on companies with strong execution capabilities and diversified client portfolios below recent support levels.|Quick check: PGHL bullish bias (+0.3% 1d), HONAUT bearish bias (-0.2% 1d).
Mint10 days ago+3.5

iPhone-maker Apple cuts over 200 jobs across Siri, Vision Pro teams to focus on new devices, AI: Details

5 factsInformation Technology
Maintain a neutral to slightly positive bias on Indian IT stocks, focusing on companies with strong AI capabilities and diversified client portfolios.|Quick check: MARUTI bearish bias (oversold).
Economic Times10 days ago+34.1

Karnataka launches KEO to take AI-ready computing to homes, schools and rural communities: DK Shivakumar

Bearish5 factsTECHMInformation TechnologyElectronics Manufacturing
Maintain a bullish bias on Indian IT services and electronics manufacturing stocks, looking for entry points on dips, with a focus on companies with strong government sector exposure or relevant product offerings.|Quick check: TECHM bearish bias (oversold).
Mint11 days ago+7.5

'Smallest wearable on the market': Deepinder Goyal says Temple is now less than half its earlier size, pre-orders soon

Neutral5 factsZOMATOBroad Market
Neutral to slightly positive for ZOMATO based on innovation, but no immediate trading action warranted.|Quick check: ZOMATO neutral.
Economic Times11 days ago+39.2

Medical devices industry needs to focus more on local value addition: Pharma Secy

5 factsHealthcarePharmaceuticals
Maintain a bullish bias on Indian medical device manufacturers with strong R&D and manufacturing capabilities, looking for entry points on dips below key support levels.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA neutral (+1.1% 1d).
Mint11 days ago+6.8

Acer wants to be more than a PC brand. Can ‘House of Acer’ crack India’s crowded consumer market?

5 factsConsumer DurablesElectronics
Maintain a neutral to cautious bias on Indian consumer durable stocks; watch for signs of pricing pressure or market share erosion due to new entrants.|Quick check: MARUTI neutral (+1.2% 1d), TATAMOTORS bearish bias (oversold).
Mint12 days ago+12.8

Ola launches ‘introductory offer’ for home inverter Shakti Gen2 — Check discounted pricing here

5 factsConsumer DurablesElectrical Equipment
Consider a cautious stance on traditional battery and inverter manufacturers, monitoring their response to new competition; look for potential long-term opportunities in companies adapting to the evolving energy storage landscape.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (oversold).
Economic Times12 days ago+46.6

Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027

5 factsHealthcareDiagnostics
Consider a long bias on Indian healthcare and diagnostics stocks, particularly those with strong R&D pipelines and expansion strategies, with a focus on companies demonstrating clear growth catalysts.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (oversold).
Economic Times12 days ago+34.8

ET Exclusive: Elon Musk's Starlink reapplies for India approval of satellite network with direct-to-device tech

Bearish5 factsTCSTelecommunicationsInformation Technology
Maintain a cautious stance on traditional telecom stocks; consider short-term volatility. Look for potential long-term opportunities in IT services supporting new age communication infrastructure.|Quick check: TCS bearish bias (oversold), HDFCBANK bearish bias (oversold).
Economic Times14 days ago+59.9

Tata Group's satcom arm invests $20 million in US-based Elveo to expand connectivity

Neutral5 factsNELCOTATASTEELTATAMOTORSTelecommunicationAutomotive
Maintain a bullish bias on companies providing enabling technologies for the auto sector's digital transformation, with a focus on long-term growth potential.|Quick check: NELCO bullish bias (-1.4% 1d), TATASTEEL neutral (+1.4% 1d).
Economic Times18 days ago+49.6

Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEO

Bullish5 factsGLANDDRLPharma
Neutral to cautiously optimistic for Gland Pharma; await clarity on new CEO's strategic direction.|Quick check: GLAND bullish bias (overbought), DRL bullish bias (overbought).
Economic Times18 days ago+19.6

Narayana Health, NDB sign pact to share smart hospital expertise

Bearish5 factsNHHealthcareHospitals & Healthcare Services
Maintain a bullish bias on healthcare providers embracing digital transformation; look for entry points in NH with a focus on long-term growth potential.|Quick check: NH bearish bias (oversold), HDFCBANK bearish bias (oversold).
Economic Times19 days ago+22.5

India needs to step up public investment to attract private investments: Working paper by EAC-PM

5 factsBroad MarketAuto
Positive bias for capital goods, infrastructure, and manufacturing sectors; look for companies with strong order books.|Quick check: MARUTI bearish bias (-0.9% 1d), TATAMOTORS bearish bias (-1.4% 1d).
Economic Times20 days ago-53.9

Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellers

Neutral5 factsDRLALHealthcare
Maintain a cautious bias on DRLAL in the immediate term; consider short-term bearish trades or wait for price consolidation before initiating long positions.|Quick check: DRLAL neutral, TATASTEEL neutral (-1.3% 1d).
Economic Times24 days ago+61.9

IIT Guwahati develops 'E-Eye' for rapid detection of Cancer-causing heavy metals and other toxicants

Bullish5 factsIONEXCHANGWater TreatmentEnvironmental Services
This news is not directly relevant to the IT sector's core business. Traders should maintain a cautious bias on IT stocks, focusing on deal pipeline and USD/INR movements.|Quick check: IONEXCHANG bullish bias (overbought), TCS bullish bias (+3.4% 1d).
Economic Times24 days ago+59

SBI Chairman Shetty rules out asset quality stress in Q1, says seasonality distorts sequential NPAs

Neutral5 factsSBINBAJFINANCEBankingFinancial Services
Maintain a bullish bias on SBI and select PSBs, looking for entry points on minor dips below key support levels.|Quick check: SBIN bullish bias (overbought), BAJFINANCE bearish bias (-6.2% 1d).
Economic Times24 days ago+50.3

India must build export-oriented medical devices industry, says pharma secretary

Bullish5 factsHCGSTRTECHPharma
Strong bullish bias for domestic medical device manufacturers.|Quick check: HCG bullish bias (+0.3% 1d), STRTECH neutral.
Economic Times25 days ago+50.6

RBI allows gradual device restrictions for EMI defaults, eases recovery agent disclosure norms

Bearish5 factsHDFCBANKICICIBANKKOTAKBANKBankingFinance
Positive bias for banking and NBFC stocks, especially those with high exposure to consumer durable loans.|Quick check: HDFCBANK bearish bias (-0.1% 1d), ICICIBANK bullish bias (+0.6% 1d).
Economic Times25 days ago+35

Govt plans new drugs law to overhaul pharma, medical device regulation

Bullish5 factsPharma
Neutral to cautious bias; favor companies with strong compliance records and R&D capabilities.|Quick check: SUNPHARMA neutral (+0.5% 1d), CIPLA bullish bias (overbought).
Economic Times25 days ago-45.4

RBI bars banks from disabling mobile devices of defaulting borrowers

Neutral5 factsHDFCBANKICICIBANKSBINBankingFinancial Services
Maintain a cautious to bearish bias on banking stocks; look for signs of increased NPA provisioning or higher recovery costs in future earnings reports. Risk discipline is key.|Quick check: HDFCBANK bearish bias (-0.1% 1d), ICICIBANK bullish bias (+0.6% 1d).
Economic Times26 days ago+5.8

iPhone 18 Pro launch date: Apple reportedly gears up for September event

5 factsElectronicsRetail
Neutral to slightly cautious on Indian electronics manufacturers due to potential cost pressures.|Quick check: MARUTI neutral (-1.1% 1d), TATAMOTORS neutral (-1.8% 1d).
Economic Times26 days ago+66

Indo MIM shares surge 10%, extend gains to 82% over issue price. Should investors book profits?

Bullish5 factsMTARTECHASHOKLEYPrecision EngineeringAutomotive Components
Consider a 'watch on dips' strategy for quality auto component manufacturers, focusing on companies with strong order books and technological edge orders.|Quick check: MTARTECH bullish bias (+2.4% 1d), ASHOKLEY bullish bias (overbought).
Economic Times26 days ago+18.3

Ai+ launches a Rs 100 crore bug bounty programme to boost device security

5 factsAutoTechnology
Neutral for the auto sector, but potentially bullish for Indian cybersecurity solution providers in the long term.|Quick check: MARUTI bullish bias (overbought), TATAMOTORS bullish bias (overbought).
Economic Times26 days ago+16.7

AMD shares fall 6% as investors demand bigger AI payoff

Neutral5 factsPharma
No direct trade setup for Indian stocks. Indirectly, be cautious of Indian IT firms with unclear AI monetization strategies.|Quick check: SUNPHARMA neutral (-1.2% 1d), CIPLA bullish bias (overbought).
Economic Times27 days ago+45.7

Sterlite Tech, HFCL gain 5% each on reports of US ban on Chinese data centre devices

Neutral5 factsSTLTECHHFCLAutoTelecom Equipment
Strong positive bias for telecom equipment and optical fiber stocks; look for breakout opportunities.|Quick check: STLTECH bearish bias (-3.9% 1d), HFCL bullish bias (+0.0% 1d).
Economic Times28 days ago+66.7

Dr Reddy's Laboratories launches generic Sugammadex injection in the United States

Bullish5 factsDRLPharmaceuticals
Maintain a bullish bias on Dr. Reddy's Laboratories (DRL) following this significant US generic launch, with potential for short-term upside. Risk management should include monitoring broader market sentiment and any regulatory changes in the US.|Quick check: DRL bullish bias (overbought), MARUTI neutral (-0.6% 1d).
Mint28 days ago+32.4

Culture That Compounds: How Nippon India AMC Builds a Workplace the Way It Builds Wealth

Neutral5 factsNAM-INDIAFinancial ServicesAsset Management
Consider a long bias for NAM-INDIA, looking for confirmation in AUM growth and sustained financial performance below recent support levels.|Quick check: NAM-INDIA neutral (+0.3% 1d), NIFTY neutral.
Economic Times28 days ago+26

Centre mulling patient safety framework for dental implants

5 factsPharma
Neutral to cautiously negative for unorganized players; potentially positive for compliant, larger medical device companies.|Quick check: SUNPHARMA neutral (-1.2% 1d), CIPLA bullish bias (+0.2% 1d).
Economic Times29 days ago+70.7

Nifty Q1 earnings grow 11% to beat estimate, says Motilal Oswal; picks Bharti Airtel, SBI, ICICI Bank among top bets

Bullish5 factsRELIANCEJSWSTEELICICIBANKBankingFinancial Services
Consider long positions in fundamentally strong banking stocks like ICICI Bank and SBI, targeting improved NIM and credit growth below recent support levels.|Quick check: RELIANCE bullish bias (+1.2% 1d), JSWSTEEL bullish bias (+0.1% 1d).
Economic Timesabout 1 month ago-44.5

Sebi penalises SME firm Kalahridhaan Trendz, promoters for misleading disclosures

Neutral5 factsSMETextiles
Maintain a cautious bias on SME stocks; prioritize companies with strong governance and clear financial disclosures to mitigate regulatory risks.|Quick check: HDFCBANK bearish bias (oversold), ICICIBANK bullish bias (+0.3% 1d).
Economic Timesabout 1 month ago+42.5

Delhi-NCR industries get relief as CAQM extends PM norms deadline

5 factsManufacturingIndustrials
Look for short-term positive sentiment in auto ancillary stocks with significant Delhi-NCR presence, but as the relief is temporary.|Quick check: MARUTI bullish bias (+0.4% 1d), TATAMOTORS bullish bias (+1.5% 1d).
Economic Timesabout 1 month ago+30

Maneck Mulla, Ameet Naik and Neil Mandevia form real estate-focused MNM Partners alliance

5 factsReal EstateInfrastructure
Consider a long bias on select real estate and infrastructure stocks, focusing on companies with strong project pipelines and execution capabilities.|Quick check: MARUTI bullish bias (+1.8% 1d), TATAMOTORS neutral (+1.7% 1d).
Economic Timesabout 1 month ago+31.1

RIR Power Electronics ignites India's SiC revolution after successful NSE debut

5 factsBanking
Bullish for RIR Power Electronics and indirectly for companies in the EV/renewable energy ecosystem.|Quick check: HDFCBANK neutral (oversold), ICICIBANK neutral (-0.6% 1d).
Economic Timesabout 1 month ago+34.8

US Stock Market: Arm Holdings tops Q2 forecasts on AI demand, shares fall on royalty growth concerns

5 factsInformation TechnologySemiconductors
Maintain a selective bullish bias on Indian IT companies with strong AI and data center exposure, while being cautious on those heavily reliant on traditional mobile device segments.|Quick check: MARUTI bullish bias (+0.9% 1d), TATAMOTORS neutral (+1.6% 1d).
Economic Timesabout 1 month ago+53.5

Samsung's Galaxy Z Fold8 series tops 2.7 lakh pre-orders, eyes S26-level demand

5 factsElectronics RetailConsumer Durables
Positive bias for electronics retail and manufacturing support stocks.|Quick check: MARUTI bullish bias (+0.9% 1d), TATAMOTORS neutral (+1.6% 1d).
Mintabout 1 month ago+56.3

Q1 results 2026: L&T to HUL among companies to declare Q1 results today; full list here

Neutral5 factsHINDUNILVRVBLTATACAPITALInfrastructureFMCG
Adopt a 'watch on dips' or 'stay cautious into bounces' strategy around earnings for individual stocks, depending on pre-earnings sentiment and historical volatility.|Quick check: HINDUNILVR bullish bias (+1.3% 1d), VBL neutral (+1.4% 1d).
Economic Timesabout 1 month ago+68.3

Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Bullish5 factsLALPATHLABHealthcare
Bullish bias for Dr Lal Path Labs; look for consolidation before further upward movement. This news is stale, so the initial reaction has likely occurred.|Quick check: NIFTY bullish bias (+13.3% 1d).
Economic Timesabout 1 month ago+62.9

Stocks to buy in 2026 for long term: Dr Lal PathLabs, IDFC First Bank among 5 stocks that could give 10-30% return

Bullish5 factsLALPATHLABIDFCFIRSTBBanking
Bullish for Dr Lal PathLabs; consider long positions.|Quick check: LALPATHLAB bullish bias (overbought), IDFCFIRSTB bullish bias (+4.9% 1d).
Economic Timesabout 1 month ago+11.2

Despite price hikes, smartphone demand stays strong

5 factsConsumer DiscretionaryElectronics Manufacturing
Positive bias for electronics manufacturing and distribution stocks; look for entry points on dips.|Quick check: HDFCBANK bearish bias (oversold), ICICIBANK neutral (+0.7% 1d).
Economic Timesabout 1 month ago-56.8

Dr Reddy’s shares crash 9% after weak Q1 results. Here’s why these 3 brokerages are bearish

5 factsPharmaceuticals
Maintain a cautious bias on the pharma sector; consider shorting DRL on rallies or avoiding fresh long positions in the near term.|Quick check: SUNPHARMA bullish bias (+0.1% 1d), CIPLA bearish bias (-0.7% 1d).
Economic Timesabout 1 month ago+68.3

Dr Reddy’s aims to resume semaglutide supply by November after API fix

Bullish5 factsDRLPharmaceuticals
Given the positive resolution for DRL, a long bias is warranted, but monitor for any further regulatory hurdles or competitive pressures.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Economic Timesabout 1 month ago-36.7

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Bullish5 factsDRLPharma
Maintain a bearish bias on Indian pharma stocks with high US generics exposure, anticipating margin pressure.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Mintabout 1 month ago-57.4

Dr Reddy’s reports muted Q1FY27 results, net profit drops 69%

5 factsPharmaceuticals
Negative bias for Dr Reddy's; cautious approach for the broader pharma sector until more clarity emerges.|Quick check: MARUTI neutral (+0.9% 1d), TATAMOTORS bearish bias (-0.7% 1d).
Mintabout 1 month ago+44.9

Q1 results 2026: Eternal to Adani Power among companies to declare Q1 results today; full list here

Bullish4 factsADANIPOWERNESTLEINDADANIGREENBanking
High volatility expected for specific stocks; focus on post-earnings analysis and guidance.|Quick check: ADANIPOWER neutral (+0.1% 1d), NESTLEIND bullish bias (+0.2% 1d).
Economic Timesabout 1 month ago+18.8

SBI Funds IPO jackpot turns 13 employees into crorepatis; top ESOP haul hits Rs 121 crore

5 factsFinancial ServicesAsset Management
Maintain a bullish bias on established financial institutions with strong subsidiaries; consider long positions on SBIN with a focus on sustained positive sentiment.|Quick check: MARUTI bearish bias (-2.0% 1d), TATAMOTORS neutral (+0.2% 1d).
Economic Timesabout 1 month ago+45

Dr Reddy's Foundation soil testing lab set to hit 1-lakh sample mark ahead of 2026 rabi season

Bullish5 factsDRLAgricultureChemicals
Consider a long-term bullish bias for companies involved in sustainable agriculture, agri-tech, and specialized agri-inputs, with disciplined risk management.|Quick check: DRL bullish bias (overbought), TCS bullish bias (overbought).
Economic Timesabout 1 month ago-1.7

The vibration plate boom: Separating fitness fact from Instagram fiction

5 facts
Maintain a bullish bias on established pharma companies with strong pipelines and regulatory compliance, focusing on export-oriented firms benefiting from currency movements.|Quick check: SUNPHARMA bullish bias (-0.9% 1d), CIPLA bearish bias (-0.7% 1d).
Economic Timesabout 2 months ago+48.6

Screens are straining young eyes, and Alcon sees India's opportunity

Neutral5 factsTITANHealthcarePharmaceuticals
Maintain a bullish bias on Indian healthcare stocks, particularly those with exposure to ophthalmic services, medical devices, or pharmaceuticals, with a focus on long-term growth potential.|Quick check: TITAN bullish bias (overbought), MARUTI bearish bias (oversold).
Economic Timesabout 2 months ago+26

Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised

Neutral5 factsABBOTTINDIAPharmaceuticalsHealthcare
Consider a bullish bias for select Indian healthcare stocks, particularly those in diagnostics and medical devices, with a focus on companies demonstrating strong R&D and market penetration.|Quick check: ABBOTTINDIA neutral, MARUTI bearish bias (oversold).
Economic Timesabout 2 months ago+22.1

Global Market: China stocks slide as tech sell-off hits mainland markets; Alibaba lifts Hong Kong shares

5 factsInformation Technology
Maintain a cautious but opportunistic bias for Indian IT stocks; consider short-term hedges against global tech weakness while identifying long-term AI beneficiaries.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (+0.3% 1d).
Economic Timesabout 2 months ago+21.2

Jitendra Singh releases Rs 1,500 crore under third phase of Biomedical Research Career Programme

Bearish5 factsHealthcarePharmaceuticals
Long-term positive bias for healthcare, pharma, and diagnostic stocks due to increased research impetus.|Quick check: TATASTEEL bearish bias (-1.9% 1d), HINDALCO bearish bias (-1.9% 1d).
Mintabout 2 months ago+15.1

Deepinder Goyal's next big bets: $1,000 forehead wearable, $20 mn aviation investment after Zomato

Neutral5 factsZOMATOAutoHealth Tech
Neutral for Zomato. Long-term speculative interest in health tech and regional aviation startups, but no immediate listed plays.|Quick check: ZOMATO neutral, MARUTI bearish bias (oversold).
Economic Timesabout 2 months ago-1.6

After Zomato, Deepinder Goyal bets on health tech and aerospace

Bearish5 factsZOMATOAuto
Neutral for listed stocks.|Quick check: ZOMATO neutral, MARUTI bearish bias (-1.6% 1d).
Mintabout 2 months ago-12.9

Apple in talks with Khosla Ventures-backed PrismML to shrink AI models for iPhone: Report

4 factsAuto
Neutral bias for Indian stocks. No direct trading opportunity.|Quick check: MARUTI bearish bias (-1.6% 1d), TATAMOTORS bearish bias (-3.0% 1d).
Economic Timesabout 2 months ago+46.4

India mulls security certification for IoT devices

Neutral5 factsHONAUTInformation TechnologyElectronics Manufacturing
Maintain a bullish bias on auto stocks, focusing on companies with strong order books and those benefiting from the broader economic recovery and potential IoT integration opportunities.|Quick check: HONAUT neutral (+0.3% 1d), MARUTI neutral (+1.1% 1d).
Economic Timesabout 2 months ago+19.7

Singham vs scammers? Bandhan Bank brings Rohit Shetty for Cyber Cop mission

Bullish5 factsBANDHANBNKBankingFinancial Services
Maintain a neutral to slightly positive bias on Bandhan Bank due to brand-building efforts, but prioritize core financial metrics like NIM and asset quality for investment decisions.|Quick check: BANDHANBNK bullish bias (+4.8% 1d), SENSEX bullish bias (+0.5% 1d).
Economic Timesabout 2 months ago-1.3

Red light therapy is the latest fad for a glow-up as celebs swear by LED masks

5 facts
No trade setup is applicable due to irrelevance to the Indian market and miscategorization.|Quick check: MARUTI neutral (+1.1% 1d), TATAMOTORS neutral (+1.7% 1d).
Economic Timesabout 2 months ago-31.5

IndiGo gets DGCA warning over cargo spillage, dangerous goods rule violations

Neutral5 factsINDIGOAutoAviation
Short-term negative bias for INDIGO; watch for further regulatory updates.|Quick check: INDIGO neutral (+1.2% 1d), MARUTI neutral (+1.1% 1d).
Economic Timesabout 2 months ago-32

Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?

Bullish5 factsDRLPharmaceuticals
Maintain a cautious bias on DRL; look for confirmation of supply resolution before considering long positions. Monitor other pharma stocks for any spillover sentiment.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Timesabout 2 months ago-30.7

Dr Reddy’s pauses weight loss drug on quality fears

Bullish5 factsDRLTORNTPHARMPharma
Bearish bias for DRL and affected suppliers; look for short positions or avoid until clarity emerges.|Quick check: DRL bullish bias (overbought), TORNTPHARM bullish bias (overbought).
Mintabout 2 months ago-3.4

BSNL launches new satellite phone at ₹1.34 lakh in India, says 'ideal for remote ops': All you need to know

5 factsTelecommunicationsDefence
Maintain a neutral bias on the broader telecom sector based on this news; look for specific tender wins or partnership announcements from listed companies for any potential upside.|Quick check: MARUTI bearish bias (-1.9% 1d), TATAMOTORS bearish bias (-0.1% 1d).
Mintabout 2 months ago-35.8

Dr Reddy's delays semaglutide supplies due to API issue

Bullish5 factsDRLPharma
Negative bias for DRL; consider short-term bearish strategies or avoiding fresh long positions.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Timesabout 2 months ago-40.8

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

Bullish5 factsDRLPharmaceuticals
Maintain a cautious stance on DRL in the short term, looking for clarity on the supply issue resolution. Consider short positions or avoiding fresh long positions until the situation stabilizes.|Quick check: DRL bullish bias (overbought), SUNPHARMA neutral (-0.8% 1d).
Economic Timesabout 2 months ago-47.1

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Bullish5 factsDRLPharmaceuticals
Given the negative news for DRL, a bearish bias is warranted for the stock in the short term. Traders should look for confirmation of downward momentum.|Quick check: DRL bullish bias (overbought), NIFTY neutral (+33.5% 1d).
Economic Timesabout 2 months ago+41.1

Opportunity worth $35 billion for medtech sector in India by 2030: Bain & Co

Bearish5 factsPOLYMEDSIEMENSHealthcareMedical Devices
Consider a long-term accumulation strategy for fundamentally strong medtech companies, focusing on those with a clear competitive advantage and export potential, with strict risk management.|Quick check: POLYMED bearish bias (-2.6% 1d), SIEMENS bearish bias (oversold).
dr devi shetty News, Mentions & Market Context | Anadi Algo News